Pulsatile changes in free fatty acids augment hepatic glucose production and preserves peripheral glucose homeostasis

American Journal of Physiology - Endocrinology and Metabolism

Volumn 299, Issue 1, 2010, Pages

  Hsu, Isabel R ^a   Zuniga, Edward ^a   Bergman, Richard N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Lipolysis; Octanoate; Oscillations; Sympathetic nervous system

Indexed keywords

BUPRANOLOL; FATTY ACID; GLUCOSE; INSULIN; OCTANOIC ACID; SODIUM CHLORIDE;

ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIET RESTRICTION; DOG; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PULSATILE FLOW;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL CLOCKS; BUPRANOLOL; DOGS; FATTY ACIDS, NONESTERIFIED; GLUCOSE; HOMEOSTASIS; LIVER; MALE;

EID: 77953447555     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00427.2009     Document Type: Article

References (30)

1. Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, Berria R, DeFronzo RA, Cusi K. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54: 1640-1648, 2005. (Pubitemid 40770753)
2. Boden G. Free fatty acids (FFA), a link between obesity and insulin resistance. Front Biosci 3: D169-D175, 1998.
3. Boden G, Chen X, Capulong E, Mozzoli M. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 50: 810-816, 2001. (Pubitemid 32242638)
4. Boden G, Jadali F. Effects of lipid on basal carbohydrate metabolism in normal men. Diabetes 40: 686-692, 1991.
5. Bradley DC, Steil GM, Bergman RN. OOPSEG: a data smoothing program for quantitation and isolation of random measurement error. Comput Methods Programs Biomed 46: 67-77, 1995.
6. Chen X, Iqbal N, Boden G. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 103: 365-372, 1999. (Pubitemid 29069986)
7. 2-receptors in the dog. Am J Physiol Endocrinol Metab 279: E463-E473, 2000.
8. Conca W, Beck A, Bacher S, Raberger G. Plasma insulin levels and beta-adrenoceptor antagonists. The effects of cardioselective and non-cardioselective beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity on basal insulin level and insulin level after glucose stimulation in normoglycemic dogs. Naunyn Schmiedebergs Arch Pharmacol 320: 63-66, 1982.
9. Finegood DT, Bergman RN, Vranic M. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36: 914-924, 1987.
10. Getty L, Panteleon AE, Mittelman SD, Dea MK, Bergman RN. Rapid oscillations in omental lipolysis are independent of changing insulin levels in vivo. J Clin Invest 106: 421-430, 2000. (Pubitemid 30655642)
11. Gonzalez-Manchon C, Ayuso MS, Parrilla R. Control of hepatic gluconeogenesis: role of fatty acid oxidation. Arch Biochem Biophys 271: 1-9, 1989.
12. Gormsen LC, Jessen N, Gjedsted J, Gjedde S, Norrelund H, Lund S, Christiansen JS, Nielsen S, Schmitz O, Moller N. Dose-response effects of free fatty acids on glucose and lipid metabolism during somatostatin blockade of growth hormone and insulin in humans. J Clin Endocrinol Metab 92: 1834-1842, 2007.
13. Hucking K, Hamilton-Wessler M, Ellmerer M, Bergman RN. Burst-like control of lipolysis by the sympathetic nervous system in vivo. J Clin Invest 111: 257-264, 2003.
14. Karpe F, Fielding BA, Coppack SW, Lawrence VJ, Macdonald IA, Frayn KN. Oscillations of fatty acid and glycerol release from human subcutaneous adipose tissue in vivo. Diabetes 54: 1297-1303, 2005. (Pubitemid 40586657)
15. Keller U, Turkalj I, Laager R, Bloesch D, Bilz S. Effects of medium-and long-chain fatty acids on whole body leucine and glucose kinetics in man. Metabolism 51: 754-760, 2002.
16. Komjati M, Bratusch-Marrain P, Waldhausl W. Superior efficacy of pulsatile versus continuous hormone exposure on hepatic glucose production in vitro. Endocrinology 118: 312-319, 1986. (Pubitemid 16147574)
17. Lam TKT, Van de Werve G, Giacca A. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. Am J Physiol Endocrinol Metab 284: E281-E290, 2003. (Pubitemid 36120100)
18. Magnusson I, Rothman DL, Gerard DP, Katz LD, Shulman GI. Contribution of hepatic glycogenolysis to glucose production in humans in response to a physiological increase in plasma glucagon concentration. Diabetes 44: 185-189, 1995.
19. Matthews DR, Naylor BA, Jones RG, Ward GM, Turner RC. Pulsatile insulin has greater hypoglycemic effect than continuous delivery. Diabetes 32: 617-621, 1983.
20. Mittelman SD, Bergman RN. Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin. Am J Physiol Endocrinol Metab 279: E630-E637, 2000.
21. Paolisso G, Buonocore S, Gentile S, Sgambato S, Varricchio M, Scheen A, D'Onofrio F, Lefebvre PJ. Pulsatile glucagon has greater hyperglycaemic, lipolytic and ketogenic effects than continuous hormone delivery in man: effect of age. Diabetologia 33: 272-277, 1990. (Pubitemid 20161881)
22. Paolisso G, Scheen AJ, Albert A, Lefebvre PJ. Effects of pulsatile delivery of insulin and glucagon in humans. Am J Physiol Endocrinol Metab 257: E686-E696, 1989.
23. Paolisso G, Scheen AJ, Giugliano D, Sgambato S, Albert A, Varricchio M, D'Onofrio F, Lefebvre PJ. Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency. J Clin Endocrinol Metab 72: 607-615, 1991. (Pubitemid 21921738)
24. Paolisso G, Scheen AJ, Luyckx AS, Lefebvre PJ. Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man. Am J Physiol Endocrinol Metab 252: E1-E7, 1987.
25. Paolisso G, Scheen AJ, Verdin EM, Luyckx AS, Lefebvre PJ. Insulin oscillations per se do not affect glucose turnover parameters in normal man. J Clin Endocrinol Metab 63: 520-525, 1986. (Pubitemid 16035709)
26. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14: 263-283, 1998.
27. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97: 2859-2865, 1996. (Pubitemid 26197099)
28. Roden M, Stingl H, Chandramouli V, Schumann WC, Hofer A, Landau BR, Nowotny P, Waldhausl W, Shulman GI. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 49: 701-707, 2000. (Pubitemid 30339983)
29. Schmitz O, Brock B, Hollingdal M, Juhl CB, Porksen N. High-frequency insulin pulsatility and type 2 diabetes: from physiology and pathophysiology to clinical pharmacology. Diabetes Metab 28: 4S14-4S20, 2002.
30. Staehr P, Hother-Nielsen O, Landau BR, Chandramouli V, Holst JJ, Beck-Nielsen H. Effects of Free Fatty Acids Per Se on Glucose Production, Gluconeogenesis, and Glycogenolysis. Diabetes 52: 260-267, 2003.